Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Test results

19 May 2009 08:00

RNS Number : 4559S
Plant Health Care PLC
19 May 2009
 



19 May 2009

Plant Health Care plc 

("Plant Health Care" or "the Company")

The Journal of the American Society of Horticultural Science recently published the findings of an extensive testing and research progamme carried out on Plant Health Care's harpin product when used with lettuce (J. AMER. SOC. HORT. SCI. 134(1):141-147. 2009.). 

A summary of the findings is set out below.


 

 

Researchers from three US academic institutions (Rutgers University, University of California, Davis and University of Arizona), led by Dr. Jorge M. Fonseca at the University of Arizona's Yuma Agricultural Center, have investigated the effect of a pre-harvest treatment of head lettuce with Plant Health Care's harpin protein which is known to boost plants' growth processes and resistance to disease.

Lettuce plants grown at the three locations were treated, five days before harvest with three different rates of the harpin A/B second generation protein. After processing and bagging the lettuces were cool-stored and their quality evaluated over a period of 20 days.

At the two higher rates, the harpin-treated lettuce from California consistently showed better visual quality and lower microbial population than the control. Similarly in Arizona, for part of the storage period, microbial population was lower and visual quality was higher in lettuce treated with harpin at the two higher rates. Overall results in New Jersey showed no major differences among treatments. 

In additional experiments it was shown that antioxidants increased by 40% in head leaves when plants were treated with the two higher rates of harpin, but no visible changes were observed in outer leaves. Furthermore, phenolic content was higher in all treated lettuce than in the control lettuce after 24 hours. Six days later, the levels fell back to the initial stage. 

Overall, it was shown that a pre-harvest, field application of harpin can improve quality of fresh-cut head lettuce under certain environmental conditions. The results with antioxidant activity and phenolic content suggest that improvement in quality is probably the result of alteration of metabolites' composition.

The study clearly shows the potential for harpin use as a pre-harvest treatment to improve several important health and appearance-related aspects of this important produce crop.

- ends -

Enquiries:

Plant Health Care plc

John Brady, Chief Executive Officer

Tel: +1-603-525-3702

jabrady@planthealthcare.com

Evolution Securities

Tavistock Communications 

Tim Worlledge / Tim Redfern

Jeremy Carey/Matt Ridsdale

Tel: +44-20-7071-4300 

Tel: +44-20-7920-3150

tim.worlledge@evosecuties.com

tim.redfern@evosecuties.com

jcarey@tavistock.co.uk

mridsdale@tavistock.co.uk

About Plant Health Care plc:

Plant Health Care plc is a leading provider of natural products for plants and soil. Established in 1995 in Pittsburgh (Pennsylvania) in the United States, Plant Health Care currently has approximately 90 employees and has operations in the United States, Mexico, the United Kingdom, Spain, and the Netherlands. The Company listed on the AIM market of the London Stock Exchange in July 2004. Ticker symbol is PHC.

Plant Health Care's products are aimed at the agriculture and landscape industries and are environmentally beneficial. Through the commercialisation of these products, Plant Health Care is capitalising on current long-term trends toward natural systems and biological products for plant care and soil and water management. Further information is available at: www.planthealthcare.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAEAKSPFLLNEFE
Date   Source Headline
27th Sep 20075:19 pmRNSDirector/PDMR Shareholding
27th Sep 20077:01 amRNSPlacing
24th Sep 20077:03 amRNSHalf Year Results
24th Sep 20077:02 amRNSMyconate Trial Results
31st Aug 200710:14 amRNSTotal Voting Rights
28th Aug 20071:00 pmRNSStock Award
23rd Aug 200710:14 amRNSNotice of Results
13th Aug 20074:15 pmRNSAIM Rule 26 Information
13th Aug 200711:55 amRNSHolding(s) in Company
13th Aug 20078:49 amRNSHolding(s) in Company
31st Jul 200711:39 amRNSTotal Voting Rights
27th Jul 20077:01 amRNSN-Hibit Trial Results
25th Jul 20071:38 pmRNSAdditional Listing
23rd Jul 200711:35 amRNSDirector/PDMR Shareholding
2nd Jul 20072:25 pmRNSTotal Voting Rights
27th Jun 20077:01 amRNSProduct Update
11th Jun 20075:53 pmRNSHolding(s) in Company
8th Jun 20075:03 pmRNSAGM Statement
4th Jun 20077:31 amRNSTotal Voting Rights
17th May 20077:01 amRNSBoard Change
14th May 20077:00 amRNSNotice of AGM
1st May 20073:25 pmRNSTotal Voting Rights
26th Apr 20079:23 amRNSAnnual Report and Accounts
19th Apr 20071:22 pmRNSDirector/PDMR Shareholding
18th Apr 20075:42 pmRNSDirector/PDMR Shareholding
16th Apr 20077:02 amRNSFinal Results
16th Apr 20077:02 amRNSSuccessful Trial Results
30th Mar 20074:54 pmRNSTotal Voting Rights
30th Mar 20074:51 pmRNSHolding(s) in Company
23rd Mar 20076:19 pmRNSHolding(s) in Company
13th Mar 20079:01 amRNSNotice of Results
5th Mar 20075:36 pmRNSExercise of Options
5th Mar 20075:20 pmRNSHolding(s) in Company
5th Mar 20078:04 amRNSHolding(s) in Company
1st Mar 20073:33 pmRNSTotal Voting Rights
1st Mar 20077:04 amRNSRe Acquisition
15th Feb 20079:04 amRNSPartnership
8th Feb 200712:13 pmRNSAdditional Listing
6th Feb 20075:52 pmRNSAdditional Listing
5th Feb 200710:19 amRNSHolding(s) in Company
2nd Feb 20078:40 amRNSHolding(s) in Company
31st Jan 20077:01 amRNSDirector/PDMR Shareholding
24th Jan 200712:01 pmRNSHolding(s) in Company
19th Jan 200712:24 pmRNSTotal Voting Rights
18th Jan 20076:06 pmRNSDirector/PDMR Shareholding
17th Jan 20077:01 amRNSMyconate Agreement
17th Jan 20077:01 amRNSTrading Statement
15th Jan 200710:42 amRNSMyconate Update
5th Jan 20079:01 amRNSExercise of Options
20th Dec 20064:14 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.